Phase 3 Studies Herald More Options for Metastatic Breast Cancer
Dr Alan Lyss details the results and clinical implications of the EMERALD, PHOEBE, and DESTINY-Breast03 trials.
Latest Features
LATEST ARTICLES
Aesthetic Treatments for Post-Cancer Care
Cancer treatments may negatively affect the skin in a variety of ways, but aesthetic treatments can improve the skin’s appearance and patients’ quality of life.
COVID-19 and Lung Cancer: What We Know and Don’t Know
Researchers have summarized what is known about COVID-19 in the context of lung cancer and highlighted areas where more research is needed.
Cardiovascular Disease in Breast Cancer: Better Preventative Strategies Needed
Cardiovascular disease remains a leading cause of death among breast cancer survivors.
Cancer Patients May Have Double the Risk of Breakthrough Infection After COVID-19 Vaccination
A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.
MIBC Tumor Subtypes May Guide Neoadjuvant Chemotherapy Use
Neoadjuvant chemotherapy response rates differed among patients with genomically unstable bladder tumors, urothelial-like bladder tumors, and basal/squamous subtypes.
Do Antibiotics Affect Outcomes of Immunotherapy in Lung Cancer?
A meta-analysis revealed inferior responses, progression-free survival, and overall survival in patients exposed to antibiotics.
Controversy Prompts Another Update to NCCN Guidelines for Prostate Cancer
After physicians voiced concerns about an active surveillance recommendation, the NCCN panel revised the guidelines.
Can Quality of Life Assessments Predict PFS, OS Across Cancer Types?
Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
Genetic Differences May Partly Explain Racial/Ethnic Disparities in Early-Onset Colorectal Cancer
Data from the GENIE registry revealed distinct genomic patterns in patients of different races/ethnicities.
Long-Term Benefit With Abemaciclib in High-Risk Early Breast Cancer
The benefit was maintained beyond the 2-year treatment period.
Docs Disagree With Update to NCCN Guidelines for Prostate Cancer
An update to active surveillance recommendations has some physicians concerned.
PTSD in Cancer Patients: What Providers Need to Know
Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Equal Access to Care May Eliminate Racial Disparities in Lung Cancer Outcomes
One study suggested that modifiable factors could improve racial disparities in the stage at which lung cancer is diagnosed.
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse
More than one-third of tumors sequenced carried a high mutation burden.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...